Fertility sparing treatment in cervical cancer management in pregnancy
| Autor: | Michael J. Halaska, Vit Drochytek, Frédéric Amant, Roman G. Shmakov |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Uterine Cervical Neoplasms Neoadjuvant chemotherapy Miscarriage 03 medical and health sciences 0302 clinical medicine Pregnancy medicine Childbirth Humans Risk factor Adverse effect Cervical cancer 030219 obstetrics & reproductive medicine Obstetrics business.industry Infant Newborn Obstetrics and Gynecology Fertility Preservation General Medicine Obstetrical management medicine.disease Management Abortion Spontaneous Fertility 030220 oncology & carcinogenesis Female business Developed country Premature rupture of membranes |
| Zdroj: | Best practiceresearch. Clinical obstetricsgynaecology. 75 |
| ISSN: | 1532-1932 |
| Popis: | The article focuses on fertility-sparing management during pregnancy and obstetrical management after fertility-sparing surgery. Over the years, more women in developed countries tend to delay childbirth to a later age, which leads to cervical cancer more often diagnosed during pregnancy. The advances in our understanding of prognosis and treatment options in these patients have helped us to address avenues and to circumvent standard therapy and fetal demise, respecting maternal and fetal chances. Childbearing trends also lead to an increase in the number of patients considering fertility-sparing management when diagnosed with cervical cancer. Such management represents a challenge for obstetricians as prior cervical surgery is a known risk factor for various adverse events. These include decreased fertility, second trimester miscarriage, preterm labor, or preterm premature rupture of membranes. Watchful follow-up and various prophylactic measures are keys when striving for the best possible outcome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect